# A Proof-of-Concept Study Investigating the Safety and Efficacy of ZT-031 on Hip Fracture Healing in Men and Postmenopausal Women

> **NCT00787358** · PHASE2 · WITHDRAWN · sponsor: **Zelos Therapeutics** · enrollment: 50 (estimated)

## Conditions studied

- Hip Fracture

## Interventions

- **DRUG:** ZT-031
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00787358
- **Lead sponsor:** Zelos Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-12
- **Primary completion:** 2009-06
- **Final completion:** 2009-07
- **Target enrollment:** 50 (ESTIMATED)
- **Why stopped:** Change in company direction
- **Last updated:** 2009-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00787358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00787358, "A Proof-of-Concept Study Investigating the Safety and Efficacy of ZT-031 on Hip Fracture Healing in Men and Postmenopausal Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00787358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*